In this interview, Gilles Montalescot, MD, PhD, discusses the significant impact of US funding cuts on global medical research and the potential for Europe to step in.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Immune checkpoint (IC) inhibitor drug holidays are safe in patients with metastatic melanoma who achieve an objective ...

Castleman disease is an idiopathic, rare lymphoproliferative disorder. It is classified as multicentric Castleman disease, ...

Real-world data show that adjuvant therapy, not complete nodal dissection, is crucial for preventing relapse in patients with stage III melanoma.

Among young competitive athletes in the United States, survival after sudden cardiac arrest has improved over time, but ...

Some neurologists and a consumer watchdog worry that an Eli Lilly–affiliated direct-to-consumer telehealth platform for ...

While skin cancer rates are growing in many parts of the world, experts disagree on whether this represents a true epidemic or overdiagnosis is a contributing factor.

Stopping prophylactic treatment in patients with rheumatic disease on > 12.5 mg/d of prednisone-equivalent corticosteroids ...

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...

This difficult patient pushes clinical staff to their limits — but his quiet, unnoticed decline exposes critical issues in ...